JSR Life Sciences Launches 'Similis Bio' to Help Partners Accelerate Biosimilar Development
JSR Life Sciences, LLC (JSR) today announced the launch of a new business division, Similis Bio (Similis), which will operate a partnering program designed to help biopharmaceutical companies improve the efficiency and cost of biosimilar development. Similis will rely on core expertise in developing and manufacturing biologics to mitigate the challenges inherent in biosimilar drug development.
Similis provides biosimilar drug developers with solutions designed to accelerate development timelines and lower costs. By offering complete analytical and process development packages, Similis supplies companies with data to determine an appropriate biosimilar target, accelerate early program development, and reduce analytical costs. Data packages include reference product data, analytical procedures, process expertise, and CMC templates from a centralized model designed to give partners access to higher quality biosimilar packages at a lower cost than other development models.
Additionally, Similis will establish co-development agreements with partner companies to start the development of multiple biosimilar programs in parallel, giving partners an exclusive right, but not an obligation, to purchase multiple programs. JSR designed this collaboration model to reduce the risk from program cancellations and extend market analysis timelines.
“This model will enable changes in strategy far beyond traditional drug development approaches by centralizing reference product data and expertise under one roof,” said JSR Life Sciences’ Chief Technology Officer Jean-Pierre Wery. “Similis brings the broad expertise of JSR Life Sciences companies together to jump-start the development of promising biosimilars. By improving timelines and development costs for drug makers, more biosimilars can be brought to market faster. Ultimately, that means more choice and lower costs for patients.”
Biosimilars—the generic form of FDA-approved biologics—are derived from living organisms, making them inherently complex. Unlike small-molecule generic drugs, biosimilars cannot fully replicate their brand-name counterparts, so an array of analytical data must be collected to ensure they sufficiently reflect biosimilarity to the FDA-approved reference products to which they are being compared. This process requires costly and significant investment in expertise, state-of-the-art technology, and extensive data gathering, including rigorous clinical trials to ensure a biosimilar's safety and efficacy. JSR launched Similis Bio to mitigate these barriers to market entry and promote more productive development programs.
For more information about Similis Bio visit: JSRLifeSciences.com/similis.
About JSR Life Sciences, LLC
A business unit of JSR Corporation, JSR Life Sciences, LLC is changing human health as a strategic partner and pathfinder for the life sciences industry. Rooted in a history of materials innovation, JSR Life Sciences provides specialized products, materials, and services to biopharmaceutical companies and academic researchers. Together with its world-class affiliates, JSR Life Sciences offers best-in-class integrated services that de-risk molecule selection, accelerate biologic development timelines, increase clinical success rates, and develop novel in vitro diagnostics. JSR Life Sciences’ global network of affiliates includes Crown Bioscience, KBI Biopharma, Inc., Selexis SA, and MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. The company operates R&D and applications labs, manufacturing facilities, and sales offices worldwide. For more information, visit JSRLifeSciences.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005401/en/
JSR Life Sciences Company Inquiries
Director, Marketing & Communications
JSR Life Sciences Media Inquiries
Sam Brown Inc.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GMS ranked as a Tier 1 SMS Firewall Vendor by ROCCO Research30.5.2023 10:00:00 CEST | Press release
Global Message Services (GMS), a trusted communications service provider for Enterprises and Mobile Operators worldwide, has been rated as a Tier 1 SMS Firewall Vendor in the ROCCO SMS Firewall Benchmarking Survey, for a second year running. This year, GMS topped the Tier 1 leaderboard featuring six vendors, attaining an overall rating of 4.53 out of 5. It received top scores for a range of KPIs, including reliability, customer service, technical expertise, transparency, and industry awareness. It also achieved a net promoter score of 93 - the best among all the vendors who participated. For the 2023 edition of this annual survey, ROCCO Research collected feedback from 239 MNOs spread across 136 countries. Some 46% of vendors who took part in the survey reported that they have experienced an increase in SMS attacks. The survey also confirmed that despite AI advances, the human element remains essential for SMS firewall protection. Charles Upchurch, CEO, GMS said: "Even as firewall mana
Regnology Enters into Exclusive Talks to Acquire Invoke30.5.2023 08:19:00 CEST | Press release
Regnology, a leading software provider with a focus on regulatory reporting solutions, announces today it expects to sign a definitive agreement to acquire Invoke, a French-based provider of financial, regulatory, and tax reporting solutions for supervisory authorities, and reporting entities. On completion of the agreement, the deal would mark the fifth acquisition in less than a year for Regnology. With 160+ full-time employees, Invoke serves over 1,800 regulated entities and supervisory authorities throughout Europe with its XBRL-based banking, insurance, and tax reporting solutions. Invoke’s corporate tax solution will complement Regnology’s financial tax reporting solution and open a new growth area for the company. Rob Mackay, CEO of Regnology, comments: “The round of recent deals we have undertaken, culminating with today’s announcement, sets Regnology on an accelerated path for growth internationally. Invoke’s advanced solutions would complement our technology stack while its t
William O'Neil + Company Announces the Passing of William J. O'Neil30.5.2023 05:21:00 CEST | Press release
William J. O'Neil, "Bill," a highly accomplished figure in the world of stock speculation, entrepreneurship, authorship, and philanthropy has passed away at the age of 90. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230529005167/en/ William J. O'Neil (Photo: Business Wire) Bill exemplified the American spirit and firmly believed that through hard work, anyone could attain prosperity. His approach to success was characterized by his willingness to challenge conventional wisdom, carefully analyze the data, and follow it wherever it led him, on his own terms. With humble beginnings, he became the youngest person to purchase a seat on the New York Stock Exchange at 30 years old. He wrote several best-selling books sharing the investment methodologies he built his businesses upon and devoted much of his life to extending a path toward financial freedom for all. He was a vocal proponent of a free enterprise system and its contr
Huawei ICT Competition 2022-2023 Global Final Held in Shenzhen — 146 Teams from 36 Countries and Regions Win Awards30.5.2023 04:54:00 CEST | Press release
On May 27, 2023, the Huawei ICT Competition 2022-2023 Global Final concluded in Shenzhen, drawing to a close the seventh installment of this competition. The first to be held in person since 2019, the event’s culmination was a competition between finalists in 146 teams from 36 countries. Before the Final, more than 120,000 students from more than 2000 universities in 74 countries and regions around the world took part in the ICT Competition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230529005085/en/ Huawei ICT Competition 2022–2023 Global Final Closing and Awarding Ceremony (Photo: Huawei) Teams from Shenzhen Polytechnic, Guilin University of Electronic Technology, Guangzhou College of Commerce, Yangtze Normal University, and Hunan Industry Polytechnic won the Network Track Grand Prize. Teams from Guilin University of Electronic Technology, Shenzhen Polytechnic, and Nanning College for Vocational Technology won the Clou
Tourists from Four Asian Countries and Regions Can Now Pay in Thailand with Mobile Wallets30.5.2023 04:21:00 CEST | Press release
Ant Group, the operator of Alipay+, the global cross-border digital payments and marketing solution today announced that a total of four mobile wallets are now accepted in Thailand. These include AlipayHK (Hong Kong SAR), Kakao Pay (South Korea), Touch ‘n Go eWallet (Malaysia) and Alipay (Chinese mainland), which has been accepted by Thai merchants since 2015. Enabled through Alipay+, the latest development and the addition of three more mobile wallets will expand the seamless digital travel experience for more Asian tourists visiting Thailand, in the midst of a rapid rebound in the local tourism industry. Ant Group also unveiled new collaborations with the Tourism Authority of Thailand (“TAT”), to promote the Amazing Thailand campaign and to stimulate travel in Thailand. In addition to facilitating purchases and transactions made by mobile wallets familiar to tourists, Ant Group will also provide digital solutions to local businesses in areas such as digitalisation of service operatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom